Abstract:Background: Lung squamous cell carcinoma (LUSC) is a prevalent and lethal malignancy with a poor clinical prognosis. Major constituents of the tumor microenvironment (TME) include infiltrating immune cells and stromal cells, which play a pivotal role in the progression and growth of the disease. To improve the understanding of the prognostic influence of immune and stromal cell-related genes for patients with the disease, we performed a comprehensive bioinformatics analysis to identify TME-relevant biomarkers, and investigated the potential role of these candidate signatures in LUSC. Methods: Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) assessed the samples of LUSC obtained from The Cancer Genome Atlas (TCGA). The samples were grouped according to their immune/stromal scores (high or low). Multivariate cox regression and receiver operating characteristic curves (ROC) were implemented to construct the risk assessment model for prognosis prediction. The co-upregulated differentially expressed genes (DEGs) in the immune and stromal groups were used for further analyses. Overall survival (OS) curves were used to determine the prognostic value of the DEGs, and the TME- related DEGs were verified with Gene Expression Omnibus (GEO) datasets. The functional assessments were performed include Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein-protein interaction (PPI) analyses. Results: The immune/ stromal scores calculated by ESTIMATE showed significant associations with OS (log-rank P<0.05). In addition, the prognostic risk score model based on immune and stromal scores also showed significant correlations with OS. A total of 94 TME-related genes were obviously related to poor OS. Among them, BHMT2, FES, HSPB7, NOVA2, LPAP2, and SEMA3B (BFHNLS) were confirmed using GSE4573 and GSE17710 datasets. The functional assessments exhibited those TME-related genes mostly participate in immune response, cytokine-cytokine receptor interaction, and metabolic pathways, which elucidated the probable correlation of TME with tumorigenesis in LUSC. Conclusions: In this study, 6 potential biomarkers named BFHNLS were identified as TME-related genes with prognostic value based on immune and stromal scores of LUSC patients of TCGA, and were verified using GEO datasets, which might serve as therapeutic targets.

Identification of key genes related to the mechanism and prognosis of lung squamous cell carcinoma using bioinformatics analysis

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis

Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma from Chinese Patients.

DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysis

An Investigation to Identify Tumor Microenvironment-Related Genes of Prognostic Value in Lung Squamous Cell Carcinoma Based on the Cancer Genome Atlas

Identification of pivotal genes with prognostic evaluation value in lung adenocarcinoma by bioinformatics analysis

Identification of tumor-suppressor genes in lung squamous cell carcinoma through integrated bioinformatics analyses

Bioinformatics Analysis and Screening of Potential Target Genes Related to the Lung Cancer Prognosis

Confirmation Key Genes Associated with TNM Staging Classified as T3 and T4 in Lung Squamous Cell Carcinoma with Bioinformatics Analysis

Identification of an Immune Gene Expression Signature for Predicting Lung Squamous Cell Carcinoma Prognosis

Identification of significant genes in non-small cell lung cancer by bioinformatics analyses

Genes co-related with poor prognosis of patients with lung cancer via bioinformatical approaches

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer

Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis

High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis